Gustave Roussy
Hospitals & Physicians Clinics · France · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
114 Rue Edouard Vaillant, Villejuif, Ile...Phone Number
+33 142114211Website
www.gustaveroussy.frRevenue
$455.1 MillionIndustry
About Gustave Roussy
Gustave Roussy Org Chart
Is Gustave Roussy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Gustave Roussy launches new products
Click to see if Gustave Roussy had a recent Job posting/layoffs
Earning: See what the market has to say on Gustave Roussy recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Gustave Roussy has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Gustave Roussy
Check out if Gustave Roussy is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Gustave Roussy has new funding data
Gustave Roussy, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Gustave Roussy as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Gustave Roussy is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Gustave Roussy is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Gustave Roussy.
Gustave Roussy Tech Stack
A closer look at the technologies used by Gustave Roussy
Most Recent Scoops
Gustave Roussy News & Media
StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers
The collaboration will inform patient selection for treatment with STX-1, a first-in-class senolytic ADC directed against DPP4/CD26.Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
PARIS--(BUSINESS WIRE)--Sofinnova Partners, a leading European life sciences venture capital firm, in collaboration with Gustave Roussy, Europe’s leading cancer center, announces the creation of their first pioneering biotech company. Signadori Bio, developed with scientific founders Dr. Jean-Luc Perfettini and Professor Nathalie Chaput, is a breakthrough cell therapy platform focused on transforming cancer treatment. This milestone marks a significant achievement in their strategic partnershipAlira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention
SpherePX Technology Powers Early Detection and Personalized Prevention SpherePX Technology Powers Early Detection and Personalized Prevention
Top Hospitals & Physicians Clinics Companies
Frequently Asked Questions Regarding Gustave Roussy
Gustave Roussy is the leading cancer treatment center in Europe, focusing on innovation in cancer care and research for the benefit of patients. The institution offers a wide range of services including various cancer treatments, clinical trials, and support care. It serves a diverse clientele, including international patients and those seeking spe... Read More